nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—epilepsy syndrome	0.222	1	CbGaD
Salicylate-sodium—Magnesium salicylate—Carbamazepine—epilepsy syndrome	0.159	0.342	CrCrCtD
Salicylate-sodium—Magnesium salicylate—Oxcarbazepine—epilepsy syndrome	0.146	0.315	CrCrCtD
Salicylate-sodium—Salsalate—Carbamazepine—epilepsy syndrome	0.0831	0.179	CrCrCtD
Salicylate-sodium—Salsalate—Oxcarbazepine—epilepsy syndrome	0.0766	0.165	CrCrCtD
Salicylate-sodium—PTGS1—Diazepam—epilepsy syndrome	0.0605	0.559	CbGbCtD
Salicylate-sodium—PTGS1—Valproic Acid—epilepsy syndrome	0.0477	0.441	CbGbCtD
Salicylate-sodium—Acetylsalicylic acid—CYP2C19—epilepsy syndrome	0.000253	0.133	CrCbGaD
Salicylate-sodium—Magnesium salicylate—PTGS2—epilepsy syndrome	0.000248	0.13	CrCbGaD
Salicylate-sodium—Magnesium salicylate—ALB—epilepsy syndrome	0.000221	0.116	CrCbGaD
Salicylate-sodium—Salsalate—PTGS2—epilepsy syndrome	0.000211	0.111	CrCbGaD
Salicylate-sodium—Mesalazine—PTGS2—epilepsy syndrome	0.000183	0.0961	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—epilepsy syndrome	0.000157	0.0828	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—ALB—epilepsy syndrome	0.00014	0.0737	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—ABCB1—epilepsy syndrome	0.000134	0.0704	CrCbGaD
Salicylate-sodium—Salicylic acid—PTGS2—epilepsy syndrome	0.00013	0.0681	CrCbGaD
Salicylate-sodium—Salicylic acid—ALB—epilepsy syndrome	0.000115	0.0607	CrCbGaD
Salicylate-sodium—Salicylic acid—ABCB1—epilepsy syndrome	0.00011	0.0579	CrCbGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—AQP4—epilepsy syndrome	9.99e-05	0.00534	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	9.91e-05	0.0053	CbGpPWpGaD
Salicylate-sodium—PTGS2—S1P1 pathway—VEGFA—epilepsy syndrome	9.44e-05	0.00505	CbGpPWpGaD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	9.39e-05	0.00502	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	8.61e-05	0.0046	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	8.61e-05	0.0046	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—PLAT—epilepsy syndrome	8.53e-05	0.00456	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—CAT—epilepsy syndrome	8.32e-05	0.00445	CbGpPWpGaD
Salicylate-sodium—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—epilepsy syndrome	8.21e-05	0.00439	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—TNF—epilepsy syndrome	8.09e-05	0.00432	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Diazepam—epilepsy syndrome	7.93e-05	0.000431	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	7.93e-05	0.000431	CcSEcCtD
Salicylate-sodium—Rash—Levetiracetam—epilepsy syndrome	7.89e-05	0.000429	CcSEcCtD
Salicylate-sodium—Dermatitis—Levetiracetam—epilepsy syndrome	7.88e-05	0.000429	CcSEcCtD
Salicylate-sodium—Asthenia—Zonisamide—epilepsy syndrome	7.88e-05	0.000428	CcSEcCtD
Salicylate-sodium—Headache—Levetiracetam—epilepsy syndrome	7.84e-05	0.000426	CcSEcCtD
Salicylate-sodium—Erythema—Gabapentin—epilepsy syndrome	7.83e-05	0.000426	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Clonazepam—epilepsy syndrome	7.8e-05	0.000424	CcSEcCtD
Salicylate-sodium—Dizziness—Vigabatrin—epilepsy syndrome	7.78e-05	0.000423	CcSEcCtD
Salicylate-sodium—Confusional state—Valproic Acid—epilepsy syndrome	7.77e-05	0.000422	CcSEcCtD
Salicylate-sodium—Pruritus—Zonisamide—epilepsy syndrome	7.77e-05	0.000422	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Phenytoin—epilepsy syndrome	7.74e-05	0.000421	CcSEcCtD
Salicylate-sodium—Flatulence—Gabapentin—epilepsy syndrome	7.71e-05	0.000419	CcSEcCtD
Salicylate-sodium—Oedema—Valproic Acid—epilepsy syndrome	7.71e-05	0.000419	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Valproic Acid—epilepsy syndrome	7.71e-05	0.000419	CcSEcCtD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—epilepsy syndrome	7.7e-05	0.00412	CbGpPWpGaD
Salicylate-sodium—Urticaria—Lamotrigine—epilepsy syndrome	7.7e-05	0.000419	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.7e-05	0.000419	CcSEcCtD
Salicylate-sodium—Nausea—Propofol—epilepsy syndrome	7.69e-05	0.000418	CcSEcCtD
Salicylate-sodium—Vomiting—Fosphenytoin—epilepsy syndrome	7.68e-05	0.000418	CcSEcCtD
Salicylate-sodium—Diarrhoea—Felbamate—epilepsy syndrome	7.68e-05	0.000417	CcSEcCtD
Salicylate-sodium—Body temperature increased—Lamotrigine—epilepsy syndrome	7.67e-05	0.000417	CcSEcCtD
Salicylate-sodium—Abdominal pain—Lamotrigine—epilepsy syndrome	7.67e-05	0.000417	CcSEcCtD
Salicylate-sodium—Dysgeusia—Gabapentin—epilepsy syndrome	7.66e-05	0.000417	CcSEcCtD
Salicylate-sodium—Dizziness—Diazepam—epilepsy syndrome	7.66e-05	0.000417	CcSEcCtD
Salicylate-sodium—Infection—Valproic Acid—epilepsy syndrome	7.66e-05	0.000416	CcSEcCtD
Salicylate-sodium—Syncope—Pregabalin—epilepsy syndrome	7.65e-05	0.000416	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CXCL2—epilepsy syndrome	7.65e-05	0.00409	CbGpPWpGaD
Salicylate-sodium—Rash—Fosphenytoin—epilepsy syndrome	7.62e-05	0.000414	CcSEcCtD
Salicylate-sodium—Dermatitis—Fosphenytoin—epilepsy syndrome	7.61e-05	0.000414	CcSEcCtD
Salicylate-sodium—Asthenia—Clonazepam—epilepsy syndrome	7.59e-05	0.000413	CcSEcCtD
Salicylate-sodium—Headache—Fosphenytoin—epilepsy syndrome	7.57e-05	0.000411	CcSEcCtD
Salicylate-sodium—Hepatitis—Topiramate—epilepsy syndrome	7.56e-05	0.000411	CcSEcCtD
Salicylate-sodium—Palpitations—Pregabalin—epilepsy syndrome	7.54e-05	0.00041	CcSEcCtD
Salicylate-sodium—Asthenia—Phenytoin—epilepsy syndrome	7.54e-05	0.00041	CcSEcCtD
Salicylate-sodium—Nausea—Midazolam—epilepsy syndrome	7.53e-05	0.000409	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Topiramate—epilepsy syndrome	7.53e-05	0.000409	CcSEcCtD
Salicylate-sodium—Hallucination—Topiramate—epilepsy syndrome	7.53e-05	0.000409	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—GPX1—epilepsy syndrome	7.52e-05	0.00402	CbGpPWpGaD
Salicylate-sodium—Tachycardia—Valproic Acid—epilepsy syndrome	7.52e-05	0.000409	CcSEcCtD
Salicylate-sodium—Diarrhoea—Zonisamide—epilepsy syndrome	7.51e-05	0.000409	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Pregabalin—epilepsy syndrome	7.5e-05	0.000408	CcSEcCtD
Salicylate-sodium—Asthenia—Oxcarbazepine—epilepsy syndrome	7.5e-05	0.000408	CcSEcCtD
Salicylate-sodium—Pruritus—Clonazepam—epilepsy syndrome	7.49e-05	0.000407	CcSEcCtD
Salicylate-sodium—Vomiting—Vigabatrin—epilepsy syndrome	7.49e-05	0.000407	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.45e-05	0.000405	CcSEcCtD
Salicylate-sodium—Pruritus—Phenytoin—epilepsy syndrome	7.44e-05	0.000404	CcSEcCtD
Salicylate-sodium—Nausea—Levetiracetam—epilepsy syndrome	7.43e-05	0.000404	CcSEcCtD
Salicylate-sodium—Rash—Vigabatrin—epilepsy syndrome	7.42e-05	0.000404	CcSEcCtD
Salicylate-sodium—Dizziness—Felbamate—epilepsy syndrome	7.42e-05	0.000403	CcSEcCtD
Salicylate-sodium—Dermatitis—Vigabatrin—epilepsy syndrome	7.42e-05	0.000403	CcSEcCtD
Salicylate-sodium—Pruritus—Oxcarbazepine—epilepsy syndrome	7.4e-05	0.000402	CcSEcCtD
Salicylate-sodium—Convulsion—Pregabalin—epilepsy syndrome	7.4e-05	0.000402	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—CYP2C19—epilepsy syndrome	7.39e-05	0.00395	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.39e-05	0.000402	CcSEcCtD
Salicylate-sodium—Vision blurred—Gabapentin—epilepsy syndrome	7.38e-05	0.000401	CcSEcCtD
Salicylate-sodium—Headache—Vigabatrin—epilepsy syndrome	7.38e-05	0.000401	CcSEcCtD
Salicylate-sodium—Vomiting—Diazepam—epilepsy syndrome	7.37e-05	0.000401	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—CYP11A1—epilepsy syndrome	7.35e-05	0.00393	CbGpPWpGaD
Salicylate-sodium—Anorexia—Valproic Acid—epilepsy syndrome	7.35e-05	0.000399	CcSEcCtD
Salicylate-sodium—Rash—Diazepam—epilepsy syndrome	7.31e-05	0.000397	CcSEcCtD
Salicylate-sodium—Dermatitis—Diazepam—epilepsy syndrome	7.3e-05	0.000397	CcSEcCtD
Salicylate-sodium—Chest pain—Pregabalin—epilepsy syndrome	7.27e-05	0.000395	CcSEcCtD
Salicylate-sodium—Dizziness—Zonisamide—epilepsy syndrome	7.26e-05	0.000395	CcSEcCtD
Salicylate-sodium—Headache—Diazepam—epilepsy syndrome	7.26e-05	0.000395	CcSEcCtD
Salicylate-sodium—Anxiety—Pregabalin—epilepsy syndrome	7.24e-05	0.000394	CcSEcCtD
Salicylate-sodium—Diarrhoea—Clonazepam—epilepsy syndrome	7.24e-05	0.000394	CcSEcCtD
Salicylate-sodium—Hypotension—Valproic Acid—epilepsy syndrome	7.2e-05	0.000392	CcSEcCtD
Salicylate-sodium—Asthenia—Carbamazepine—epilepsy syndrome	7.2e-05	0.000391	CcSEcCtD
Salicylate-sodium—Diarrhoea—Phenytoin—epilepsy syndrome	7.19e-05	0.000391	CcSEcCtD
Salicylate-sodium—Nausea—Fosphenytoin—epilepsy syndrome	7.17e-05	0.00039	CcSEcCtD
Salicylate-sodium—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.15e-05	0.000389	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Topiramate—epilepsy syndrome	7.15e-05	0.000389	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.14e-05	0.000388	CcSEcCtD
Salicylate-sodium—Vomiting—Felbamate—epilepsy syndrome	7.13e-05	0.000388	CcSEcCtD
Salicylate-sodium—Pruritus—Carbamazepine—epilepsy syndrome	7.1e-05	0.000386	CcSEcCtD
Salicylate-sodium—Rash—Felbamate—epilepsy syndrome	7.07e-05	0.000385	CcSEcCtD
Salicylate-sodium—Dermatitis—Felbamate—epilepsy syndrome	7.07e-05	0.000384	CcSEcCtD
Salicylate-sodium—Tinnitus—Topiramate—epilepsy syndrome	7.05e-05	0.000384	CcSEcCtD
Salicylate-sodium—Headache—Felbamate—epilepsy syndrome	7.03e-05	0.000382	CcSEcCtD
Salicylate-sodium—Confusional state—Pregabalin—epilepsy syndrome	7.02e-05	0.000382	CcSEcCtD
Salicylate-sodium—Syncope—Gabapentin—epilepsy syndrome	7.02e-05	0.000382	CcSEcCtD
Salicylate-sodium—Dizziness—Clonazepam—epilepsy syndrome	7e-05	0.000381	CcSEcCtD
Salicylate-sodium—Nausea—Vigabatrin—epilepsy syndrome	6.99e-05	0.00038	CcSEcCtD
Salicylate-sodium—Vomiting—Zonisamide—epilepsy syndrome	6.98e-05	0.00038	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.97e-05	0.000379	CcSEcCtD
Salicylate-sodium—Oedema—Pregabalin—epilepsy syndrome	6.97e-05	0.000379	CcSEcCtD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	6.96e-05	0.00372	CbGpPWpGaD
Salicylate-sodium—Asthenia—Lamotrigine—epilepsy syndrome	6.96e-05	0.000378	CcSEcCtD
Salicylate-sodium—Dizziness—Phenytoin—epilepsy syndrome	6.95e-05	0.000378	CcSEcCtD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—epilepsy syndrome	6.94e-05	0.00371	CbGpPWpGaD
Salicylate-sodium—Rash—Zonisamide—epilepsy syndrome	6.92e-05	0.000376	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CCR2—epilepsy syndrome	6.92e-05	0.0037	CbGpPWpGaD
Salicylate-sodium—Infection—Pregabalin—epilepsy syndrome	6.92e-05	0.000376	CcSEcCtD
Salicylate-sodium—Paraesthesia—Valproic Acid—epilepsy syndrome	6.92e-05	0.000376	CcSEcCtD
Salicylate-sodium—Palpitations—Gabapentin—epilepsy syndrome	6.92e-05	0.000376	CcSEcCtD
Salicylate-sodium—Dermatitis—Zonisamide—epilepsy syndrome	6.92e-05	0.000376	CcSEcCtD
Salicylate-sodium—Dizziness—Oxcarbazepine—epilepsy syndrome	6.91e-05	0.000376	CcSEcCtD
Salicylate-sodium—Nausea—Diazepam—epilepsy syndrome	6.88e-05	0.000374	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Gabapentin—epilepsy syndrome	6.88e-05	0.000374	CcSEcCtD
Salicylate-sodium—Headache—Zonisamide—epilepsy syndrome	6.88e-05	0.000374	CcSEcCtD
Salicylate-sodium—Dyspnoea—Valproic Acid—epilepsy syndrome	6.87e-05	0.000374	CcSEcCtD
Salicylate-sodium—Diarrhoea—Carbamazepine—epilepsy syndrome	6.87e-05	0.000373	CcSEcCtD
Salicylate-sodium—Pruritus—Lamotrigine—epilepsy syndrome	6.86e-05	0.000373	CcSEcCtD
Salicylate-sodium—Shock—Pregabalin—epilepsy syndrome	6.85e-05	0.000373	CcSEcCtD
Salicylate-sodium—Somnolence—Valproic Acid—epilepsy syndrome	6.85e-05	0.000372	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	6.83e-05	0.00365	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	6.83e-05	0.00365	CbGpPWpGaD
Salicylate-sodium—Tachycardia—Pregabalin—epilepsy syndrome	6.8e-05	0.00037	CcSEcCtD
Salicylate-sodium—Dyspepsia—Valproic Acid—epilepsy syndrome	6.78e-05	0.000369	CcSEcCtD
Salicylate-sodium—Convulsion—Gabapentin—epilepsy syndrome	6.78e-05	0.000369	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.73e-05	0.000366	CcSEcCtD
Salicylate-sodium—Vomiting—Clonazepam—epilepsy syndrome	6.73e-05	0.000366	CcSEcCtD
Salicylate-sodium—Decreased appetite—Valproic Acid—epilepsy syndrome	6.7e-05	0.000364	CcSEcCtD
Salicylate-sodium—Vomiting—Phenytoin—epilepsy syndrome	6.68e-05	0.000363	CcSEcCtD
Salicylate-sodium—Rash—Clonazepam—epilepsy syndrome	6.67e-05	0.000363	CcSEcCtD
Salicylate-sodium—Dermatitis—Clonazepam—epilepsy syndrome	6.67e-05	0.000362	CcSEcCtD
Salicylate-sodium—Chest pain—Gabapentin—epilepsy syndrome	6.66e-05	0.000362	CcSEcCtD
Salicylate-sodium—Nausea—Felbamate—epilepsy syndrome	6.66e-05	0.000362	CcSEcCtD
Salicylate-sodium—Vomiting—Oxcarbazepine—epilepsy syndrome	6.65e-05	0.000361	CcSEcCtD
Salicylate-sodium—Fatigue—Valproic Acid—epilepsy syndrome	6.64e-05	0.000361	CcSEcCtD
Salicylate-sodium—Anxiety—Gabapentin—epilepsy syndrome	6.64e-05	0.000361	CcSEcCtD
Salicylate-sodium—Anorexia—Pregabalin—epilepsy syndrome	6.64e-05	0.000361	CcSEcCtD
Salicylate-sodium—Dizziness—Carbamazepine—epilepsy syndrome	6.64e-05	0.000361	CcSEcCtD
Salicylate-sodium—Diarrhoea—Lamotrigine—epilepsy syndrome	6.63e-05	0.000361	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—CYP2D6—epilepsy syndrome	6.63e-05	0.00354	CbGpPWpGaD
Salicylate-sodium—Headache—Clonazepam—epilepsy syndrome	6.63e-05	0.00036	CcSEcCtD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—epilepsy syndrome	6.63e-05	0.00354	CbGpPWpGaD
Salicylate-sodium—Rash—Phenytoin—epilepsy syndrome	6.63e-05	0.00036	CcSEcCtD
Salicylate-sodium—Dermatitis—Phenytoin—epilepsy syndrome	6.62e-05	0.00036	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—CRP—epilepsy syndrome	6.61e-05	0.00353	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—CAT—epilepsy syndrome	6.6e-05	0.00353	CbGpPWpGaD
Salicylate-sodium—Rash—Oxcarbazepine—epilepsy syndrome	6.59e-05	0.000358	CcSEcCtD
Salicylate-sodium—Pain—Valproic Acid—epilepsy syndrome	6.59e-05	0.000358	CcSEcCtD
Salicylate-sodium—Constipation—Valproic Acid—epilepsy syndrome	6.59e-05	0.000358	CcSEcCtD
Salicylate-sodium—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.59e-05	0.000358	CcSEcCtD
Salicylate-sodium—Headache—Phenytoin—epilepsy syndrome	6.59e-05	0.000358	CcSEcCtD
Salicylate-sodium—Erythema—Topiramate—epilepsy syndrome	6.59e-05	0.000358	CcSEcCtD
Salicylate-sodium—Headache—Oxcarbazepine—epilepsy syndrome	6.55e-05	0.000356	CcSEcCtD
Salicylate-sodium—Nausea—Zonisamide—epilepsy syndrome	6.52e-05	0.000355	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	6.52e-05	0.00349	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—HES1—epilepsy syndrome	6.51e-05	0.00348	CbGpPWpGaD
Salicylate-sodium—Hypotension—Pregabalin—epilepsy syndrome	6.51e-05	0.000354	CcSEcCtD
Salicylate-sodium—Flatulence—Topiramate—epilepsy syndrome	6.49e-05	0.000353	CcSEcCtD
Salicylate-sodium—Dysgeusia—Topiramate—epilepsy syndrome	6.45e-05	0.000351	CcSEcCtD
Salicylate-sodium—Confusional state—Gabapentin—epilepsy syndrome	6.44e-05	0.00035	CcSEcCtD
Salicylate-sodium—Dizziness—Lamotrigine—epilepsy syndrome	6.41e-05	0.000349	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.39e-05	0.000347	CcSEcCtD
Salicylate-sodium—Oedema—Gabapentin—epilepsy syndrome	6.39e-05	0.000347	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	6.39e-05	0.00341	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	6.39e-05	0.00341	CbGpPWpGaD
Salicylate-sodium—Vomiting—Carbamazepine—epilepsy syndrome	6.38e-05	0.000347	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.35e-05	0.000345	CcSEcCtD
Salicylate-sodium—Infection—Gabapentin—epilepsy syndrome	6.35e-05	0.000345	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—NOS1—epilepsy syndrome	6.34e-05	0.00339	CbGpPWpGaD
Salicylate-sodium—Rash—Carbamazepine—epilepsy syndrome	6.33e-05	0.000344	CcSEcCtD
Salicylate-sodium—Dermatitis—Carbamazepine—epilepsy syndrome	6.32e-05	0.000344	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.3e-05	0.000343	CcSEcCtD
Salicylate-sodium—Nausea—Clonazepam—epilepsy syndrome	6.29e-05	0.000342	CcSEcCtD
Salicylate-sodium—Headache—Carbamazepine—epilepsy syndrome	6.29e-05	0.000342	CcSEcCtD
Salicylate-sodium—Shock—Gabapentin—epilepsy syndrome	6.28e-05	0.000342	CcSEcCtD
Salicylate-sodium—Paraesthesia—Pregabalin—epilepsy syndrome	6.26e-05	0.00034	CcSEcCtD
Salicylate-sodium—Nausea—Phenytoin—epilepsy syndrome	6.24e-05	0.00034	CcSEcCtD
Salicylate-sodium—Tachycardia—Gabapentin—epilepsy syndrome	6.23e-05	0.000339	CcSEcCtD
Salicylate-sodium—Dyspnoea—Pregabalin—epilepsy syndrome	6.21e-05	0.000338	CcSEcCtD
Salicylate-sodium—Nausea—Oxcarbazepine—epilepsy syndrome	6.21e-05	0.000338	CcSEcCtD
Salicylate-sodium—Vision blurred—Topiramate—epilepsy syndrome	6.21e-05	0.000337	CcSEcCtD
Salicylate-sodium—Somnolence—Pregabalin—epilepsy syndrome	6.19e-05	0.000337	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.18e-05	0.000336	CcSEcCtD
Salicylate-sodium—Vomiting—Lamotrigine—epilepsy syndrome	6.17e-05	0.000335	CcSEcCtD
Salicylate-sodium—Urticaria—Valproic Acid—epilepsy syndrome	6.12e-05	0.000333	CcSEcCtD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	6.12e-05	0.00327	CbGpPWpGaD
Salicylate-sodium—Rash—Lamotrigine—epilepsy syndrome	6.11e-05	0.000332	CcSEcCtD
Salicylate-sodium—Dermatitis—Lamotrigine—epilepsy syndrome	6.11e-05	0.000332	CcSEcCtD
Salicylate-sodium—Body temperature increased—Valproic Acid—epilepsy syndrome	6.09e-05	0.000331	CcSEcCtD
Salicylate-sodium—Abdominal pain—Valproic Acid—epilepsy syndrome	6.09e-05	0.000331	CcSEcCtD
Salicylate-sodium—Anorexia—Gabapentin—epilepsy syndrome	6.09e-05	0.000331	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	6.08e-05	0.00325	CbGpPWpGaD
Salicylate-sodium—Headache—Lamotrigine—epilepsy syndrome	6.07e-05	0.00033	CcSEcCtD
Salicylate-sodium—Decreased appetite—Pregabalin—epilepsy syndrome	6.06e-05	0.000329	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—APEX1—epilepsy syndrome	6.01e-05	0.00321	CbGpPWpGaD
Salicylate-sodium—Fatigue—Pregabalin—epilepsy syndrome	6.01e-05	0.000327	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—GPX1—epilepsy syndrome	5.97e-05	0.00319	CbGpPWpGaD
Salicylate-sodium—Hypotension—Gabapentin—epilepsy syndrome	5.97e-05	0.000325	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	5.96e-05	0.00319	CbGpPWpGaD
Salicylate-sodium—Nausea—Carbamazepine—epilepsy syndrome	5.96e-05	0.000324	CcSEcCtD
Salicylate-sodium—Pain—Pregabalin—epilepsy syndrome	5.96e-05	0.000324	CcSEcCtD
Salicylate-sodium—Constipation—Pregabalin—epilepsy syndrome	5.96e-05	0.000324	CcSEcCtD
Salicylate-sodium—Syncope—Topiramate—epilepsy syndrome	5.91e-05	0.000321	CcSEcCtD
Salicylate-sodium—Palpitations—Topiramate—epilepsy syndrome	5.82e-05	0.000316	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Topiramate—epilepsy syndrome	5.79e-05	0.000315	CcSEcCtD
Salicylate-sodium—Nausea—Lamotrigine—epilepsy syndrome	5.76e-05	0.000313	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	5.74e-05	0.00307	CbGpPWpGaD
Salicylate-sodium—Feeling abnormal—Pregabalin—epilepsy syndrome	5.74e-05	0.000312	CcSEcCtD
Salicylate-sodium—Paraesthesia—Gabapentin—epilepsy syndrome	5.74e-05	0.000312	CcSEcCtD
Salicylate-sodium—Convulsion—Topiramate—epilepsy syndrome	5.71e-05	0.00031	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.7e-05	0.00031	CcSEcCtD
Salicylate-sodium—Dyspnoea—Gabapentin—epilepsy syndrome	5.7e-05	0.00031	CcSEcCtD
Salicylate-sodium—Somnolence—Gabapentin—epilepsy syndrome	5.68e-05	0.000309	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.68e-05	0.000309	CcSEcCtD
Salicylate-sodium—Dyspepsia—Gabapentin—epilepsy syndrome	5.62e-05	0.000306	CcSEcCtD
Salicylate-sodium—Chest pain—Topiramate—epilepsy syndrome	5.61e-05	0.000305	CcSEcCtD
Salicylate-sodium—Anxiety—Topiramate—epilepsy syndrome	5.59e-05	0.000304	CcSEcCtD
Salicylate-sodium—Decreased appetite—Gabapentin—epilepsy syndrome	5.55e-05	0.000302	CcSEcCtD
Salicylate-sodium—Urticaria—Pregabalin—epilepsy syndrome	5.53e-05	0.000301	CcSEcCtD
Salicylate-sodium—Asthenia—Valproic Acid—epilepsy syndrome	5.53e-05	0.000301	CcSEcCtD
Salicylate-sodium—Fatigue—Gabapentin—epilepsy syndrome	5.51e-05	0.000299	CcSEcCtD
Salicylate-sodium—Abdominal pain—Pregabalin—epilepsy syndrome	5.51e-05	0.000299	CcSEcCtD
Salicylate-sodium—Body temperature increased—Pregabalin—epilepsy syndrome	5.51e-05	0.000299	CcSEcCtD
Salicylate-sodium—Constipation—Gabapentin—epilepsy syndrome	5.46e-05	0.000297	CcSEcCtD
Salicylate-sodium—Pain—Gabapentin—epilepsy syndrome	5.46e-05	0.000297	CcSEcCtD
Salicylate-sodium—Pruritus—Valproic Acid—epilepsy syndrome	5.45e-05	0.000296	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—CCL2—epilepsy syndrome	5.43e-05	0.0029	CbGpPWpGaD
Salicylate-sodium—Confusional state—Topiramate—epilepsy syndrome	5.42e-05	0.000295	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CDC42—epilepsy syndrome	5.42e-05	0.0029	CbGpPWpGaD
Salicylate-sodium—Oedema—Topiramate—epilepsy syndrome	5.37e-05	0.000292	CcSEcCtD
Salicylate-sodium—Infection—Topiramate—epilepsy syndrome	5.34e-05	0.00029	CcSEcCtD
Salicylate-sodium—Shock—Topiramate—epilepsy syndrome	5.29e-05	0.000288	CcSEcCtD
Salicylate-sodium—Diarrhoea—Valproic Acid—epilepsy syndrome	5.27e-05	0.000287	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Gabapentin—epilepsy syndrome	5.26e-05	0.000286	CcSEcCtD
Salicylate-sodium—Tachycardia—Topiramate—epilepsy syndrome	5.25e-05	0.000285	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—CRP—epilepsy syndrome	5.24e-05	0.0028	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.22e-05	0.000284	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	5.21e-05	0.00279	CbGpPWpGaD
Salicylate-sodium—Hyperhidrosis—Topiramate—epilepsy syndrome	5.2e-05	0.000283	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	5.18e-05	0.00277	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—BDNF—epilepsy syndrome	5.17e-05	0.00276	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Pregabalin—epilepsy syndrome	5.13e-05	0.000279	CcSEcCtD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—epilepsy syndrome	5.13e-05	0.00274	CbGpPWpGaD
Salicylate-sodium—Anorexia—Topiramate—epilepsy syndrome	5.12e-05	0.000279	CcSEcCtD
Salicylate-sodium—Dizziness—Valproic Acid—epilepsy syndrome	5.1e-05	0.000277	CcSEcCtD
Salicylate-sodium—Urticaria—Gabapentin—epilepsy syndrome	5.07e-05	0.000276	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—ALB—epilepsy syndrome	5.06e-05	0.00271	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CA13—epilepsy syndrome	5.06e-05	0.0027	CbGpPWpGaD
Salicylate-sodium—Abdominal pain—Gabapentin—epilepsy syndrome	5.05e-05	0.000275	CcSEcCtD
Salicylate-sodium—Body temperature increased—Gabapentin—epilepsy syndrome	5.05e-05	0.000275	CcSEcCtD
Salicylate-sodium—Hypotension—Topiramate—epilepsy syndrome	5.02e-05	0.000273	CcSEcCtD
Salicylate-sodium—Asthenia—Pregabalin—epilepsy syndrome	5e-05	0.000272	CcSEcCtD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—epilepsy syndrome	4.98e-05	0.00266	CbGpPWpGaD
Salicylate-sodium—Pruritus—Pregabalin—epilepsy syndrome	4.93e-05	0.000268	CcSEcCtD
Salicylate-sodium—Vomiting—Valproic Acid—epilepsy syndrome	4.9e-05	0.000266	CcSEcCtD
Salicylate-sodium—Rash—Valproic Acid—epilepsy syndrome	4.86e-05	0.000264	CcSEcCtD
Salicylate-sodium—Dermatitis—Valproic Acid—epilepsy syndrome	4.85e-05	0.000264	CcSEcCtD
Salicylate-sodium—Headache—Valproic Acid—epilepsy syndrome	4.83e-05	0.000262	CcSEcCtD
Salicylate-sodium—Paraesthesia—Topiramate—epilepsy syndrome	4.83e-05	0.000262	CcSEcCtD
Salicylate-sodium—Dyspnoea—Topiramate—epilepsy syndrome	4.79e-05	0.000261	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	4.78e-05	0.00255	CbGpPWpGaD
Salicylate-sodium—Somnolence—Topiramate—epilepsy syndrome	4.78e-05	0.00026	CcSEcCtD
Salicylate-sodium—Diarrhoea—Pregabalin—epilepsy syndrome	4.77e-05	0.000259	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.74e-05	0.00253	CbGpPWpGaD
Salicylate-sodium—Dyspepsia—Topiramate—epilepsy syndrome	4.73e-05	0.000257	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Gabapentin—epilepsy syndrome	4.71e-05	0.000256	CcSEcCtD
Salicylate-sodium—Decreased appetite—Topiramate—epilepsy syndrome	4.67e-05	0.000254	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	4.65e-05	0.00249	CbGpPWpGaD
Salicylate-sodium—Fatigue—Topiramate—epilepsy syndrome	4.63e-05	0.000252	CcSEcCtD
Salicylate-sodium—Dizziness—Pregabalin—epilepsy syndrome	4.61e-05	0.00025	CcSEcCtD
Salicylate-sodium—Pain—Topiramate—epilepsy syndrome	4.6e-05	0.00025	CcSEcCtD
Salicylate-sodium—Constipation—Topiramate—epilepsy syndrome	4.6e-05	0.00025	CcSEcCtD
Salicylate-sodium—Asthenia—Gabapentin—epilepsy syndrome	4.58e-05	0.000249	CcSEcCtD
Salicylate-sodium—Nausea—Valproic Acid—epilepsy syndrome	4.58e-05	0.000249	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—RELA—epilepsy syndrome	4.56e-05	0.00244	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.56e-05	0.00244	CbGpPWpGaD
Salicylate-sodium—Pruritus—Gabapentin—epilepsy syndrome	4.52e-05	0.000246	CcSEcCtD
Salicylate-sodium—Vomiting—Pregabalin—epilepsy syndrome	4.43e-05	0.000241	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	4.43e-05	0.00237	CbGpPWpGaD
Salicylate-sodium—Feeling abnormal—Topiramate—epilepsy syndrome	4.43e-05	0.000241	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.39e-05	0.000239	CcSEcCtD
Salicylate-sodium—Rash—Pregabalin—epilepsy syndrome	4.39e-05	0.000239	CcSEcCtD
Salicylate-sodium—Dermatitis—Pregabalin—epilepsy syndrome	4.39e-05	0.000239	CcSEcCtD
Salicylate-sodium—Diarrhoea—Gabapentin—epilepsy syndrome	4.37e-05	0.000238	CcSEcCtD
Salicylate-sodium—Headache—Pregabalin—epilepsy syndrome	4.36e-05	0.000237	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	4.35e-05	0.00232	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—CCL2—epilepsy syndrome	4.31e-05	0.00231	CbGpPWpGaD
Salicylate-sodium—Urticaria—Topiramate—epilepsy syndrome	4.27e-05	0.000232	CcSEcCtD
Salicylate-sodium—Body temperature increased—Topiramate—epilepsy syndrome	4.25e-05	0.000231	CcSEcCtD
Salicylate-sodium—Abdominal pain—Topiramate—epilepsy syndrome	4.25e-05	0.000231	CcSEcCtD
Salicylate-sodium—Dizziness—Gabapentin—epilepsy syndrome	4.22e-05	0.00023	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	4.14e-05	0.00221	CbGpPWpGaD
Salicylate-sodium—Nausea—Pregabalin—epilepsy syndrome	4.14e-05	0.000225	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL1B—epilepsy syndrome	4.12e-05	0.0022	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	4.07e-05	0.00218	CbGpPWpGaD
Salicylate-sodium—Vomiting—Gabapentin—epilepsy syndrome	4.06e-05	0.000221	CcSEcCtD
Salicylate-sodium—Rash—Gabapentin—epilepsy syndrome	4.03e-05	0.000219	CcSEcCtD
Salicylate-sodium—Dermatitis—Gabapentin—epilepsy syndrome	4.02e-05	0.000219	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ALB—epilepsy syndrome	4.02e-05	0.00215	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CA13—epilepsy syndrome	4.01e-05	0.00215	CbGpPWpGaD
Salicylate-sodium—Headache—Gabapentin—epilepsy syndrome	4e-05	0.000218	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	3.99e-05	0.00213	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Topiramate—epilepsy syndrome	3.96e-05	0.000215	CcSEcCtD
Salicylate-sodium—Asthenia—Topiramate—epilepsy syndrome	3.86e-05	0.00021	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—BCL2—epilepsy syndrome	3.84e-05	0.00205	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—L2HGDH—epilepsy syndrome	3.83e-05	0.00205	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PDXK—epilepsy syndrome	3.83e-05	0.00205	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CERS1—epilepsy syndrome	3.83e-05	0.00205	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—FAR1—epilepsy syndrome	3.83e-05	0.00205	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADK—epilepsy syndrome	3.83e-05	0.00205	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GLUD1—epilepsy syndrome	3.83e-05	0.00205	CbGpPWpGaD
Salicylate-sodium—Pruritus—Topiramate—epilepsy syndrome	3.8e-05	0.000207	CcSEcCtD
Salicylate-sodium—Nausea—Gabapentin—epilepsy syndrome	3.79e-05	0.000206	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—NOS2—epilepsy syndrome	3.78e-05	0.00202	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—epilepsy syndrome	3.73e-05	0.00199	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Topiramate—epilepsy syndrome	3.68e-05	0.0002	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—PDXK—epilepsy syndrome	3.63e-05	0.00194	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—RELA—epilepsy syndrome	3.62e-05	0.00193	CbGpPWpGaD
Salicylate-sodium—Dizziness—Topiramate—epilepsy syndrome	3.55e-05	0.000193	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	3.51e-05	0.00188	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PNPO—epilepsy syndrome	3.51e-05	0.00187	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—EPM2A—epilepsy syndrome	3.51e-05	0.00187	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NHLRC1—epilepsy syndrome	3.51e-05	0.00187	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GAMT—epilepsy syndrome	3.51e-05	0.00187	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	3.5e-05	0.00187	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—FOS—epilepsy syndrome	3.49e-05	0.00187	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	3.46e-05	0.00185	CbGpPWpGaD
Salicylate-sodium—Vomiting—Topiramate—epilepsy syndrome	3.42e-05	0.000186	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CCL2—epilepsy syndrome	3.41e-05	0.00182	CbGpPWpGaD
Salicylate-sodium—Rash—Topiramate—epilepsy syndrome	3.39e-05	0.000184	CcSEcCtD
Salicylate-sodium—Dermatitis—Topiramate—epilepsy syndrome	3.39e-05	0.000184	CcSEcCtD
Salicylate-sodium—Headache—Topiramate—epilepsy syndrome	3.37e-05	0.000183	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—PNPO—epilepsy syndrome	3.32e-05	0.00178	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NHLRC1—epilepsy syndrome	3.32e-05	0.00178	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EPM2A—epilepsy syndrome	3.32e-05	0.00178	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL1B—epilepsy syndrome	3.27e-05	0.00175	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CA4—epilepsy syndrome	3.26e-05	0.00174	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—QDPR—epilepsy syndrome	3.26e-05	0.00174	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—POMC—epilepsy syndrome	3.25e-05	0.00174	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.23e-05	0.00173	CbGpPWpGaD
Salicylate-sodium—Nausea—Topiramate—epilepsy syndrome	3.19e-05	0.000174	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—SV2A—epilepsy syndrome	3.09e-05	0.00165	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—COX3—epilepsy syndrome	3.06e-05	0.00164	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GLUD1—epilepsy syndrome	3.04e-05	0.00163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ADK—epilepsy syndrome	3.04e-05	0.00163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—FAR1—epilepsy syndrome	3.04e-05	0.00163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PDXK—epilepsy syndrome	3.04e-05	0.00163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—L2HGDH—epilepsy syndrome	3.04e-05	0.00163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CERS1—epilepsy syndrome	3.04e-05	0.00163	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.99e-05	0.0016	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—KCNB1—epilepsy syndrome	2.9e-05	0.00155	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PFKL—epilepsy syndrome	2.9e-05	0.00155	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CACNA2D2—epilepsy syndrome	2.9e-05	0.00155	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLCO1A2—epilepsy syndrome	2.9e-05	0.00155	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLC6A8—epilepsy syndrome	2.9e-05	0.00155	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.84e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.82e-05	0.00151	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—EPM2A—epilepsy syndrome	2.78e-05	0.00149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GAMT—epilepsy syndrome	2.78e-05	0.00149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	2.78e-05	0.00149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PNPO—epilepsy syndrome	2.78e-05	0.00149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PFKL—epilepsy syndrome	2.75e-05	0.00147	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	2.66e-05	0.00142	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—UPB1—epilepsy syndrome	2.66e-05	0.00142	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NEU1—epilepsy syndrome	2.66e-05	0.00142	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ATIC—epilepsy syndrome	2.66e-05	0.00142	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	2.59e-05	0.00138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—QDPR—epilepsy syndrome	2.59e-05	0.00138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CA4—epilepsy syndrome	2.59e-05	0.00138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	2.58e-05	0.00138	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HSD17B4—epilepsy syndrome	2.56e-05	0.00137	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—STX1B—epilepsy syndrome	2.52e-05	0.00135	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GBE1—epilepsy syndrome	2.47e-05	0.00132	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PPP1R3C—epilepsy syndrome	2.47e-05	0.00132	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	2.44e-05	0.0013	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—COX3—epilepsy syndrome	2.43e-05	0.0013	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.41e-05	0.00129	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.37e-05	0.00127	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—GBE1—epilepsy syndrome	2.34e-05	0.00125	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CPSF4—epilepsy syndrome	2.34e-05	0.00125	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PPP1R3C—epilepsy syndrome	2.34e-05	0.00125	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ASAH1—epilepsy syndrome	2.32e-05	0.00124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	2.32e-05	0.00124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—KCNB1—epilepsy syndrome	2.31e-05	0.00123	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PFKL—epilepsy syndrome	2.31e-05	0.00123	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	2.31e-05	0.00123	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	2.31e-05	0.00123	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	2.31e-05	0.00123	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—STXBP1—epilepsy syndrome	2.26e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.25e-05	0.0012	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.24e-05	0.0012	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NT5E—epilepsy syndrome	2.2e-05	0.00118	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALAD—epilepsy syndrome	2.2e-05	0.00118	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ATIC—epilepsy syndrome	2.11e-05	0.00113	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—UPB1—epilepsy syndrome	2.11e-05	0.00113	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NEU1—epilepsy syndrome	2.11e-05	0.00113	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CACNA1A—epilepsy syndrome	2.1e-05	0.00112	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALDH7A1—epilepsy syndrome	2.1e-05	0.00112	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	2.1e-05	0.00112	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ST3GAL3—epilepsy syndrome	2.05e-05	0.0011	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	2.03e-05	0.00109	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADSL—epilepsy syndrome	2.01e-05	0.00108	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.99e-05	0.00106	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GLUL—epilepsy syndrome	1.97e-05	0.00106	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	1.96e-05	0.00105	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GBE1—epilepsy syndrome	1.96e-05	0.00105	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ST3GAL3—epilepsy syndrome	1.95e-05	0.00104	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CACNA1D—epilepsy syndrome	1.94e-05	0.00104	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.92e-05	0.00102	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	1.88e-05	0.001	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ASAH1—epilepsy syndrome	1.84e-05	0.000985	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	1.81e-05	0.000969	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—STXBP1—epilepsy syndrome	1.79e-05	0.000958	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AQP1—epilepsy syndrome	1.76e-05	0.000941	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.76e-05	0.000939	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NT5E—epilepsy syndrome	1.75e-05	0.000934	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALAD—epilepsy syndrome	1.75e-05	0.000934	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.71e-05	0.000912	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.69e-05	0.000903	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	1.67e-05	0.000891	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	1.67e-05	0.000891	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	1.63e-05	0.000872	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ADSL—epilepsy syndrome	1.6e-05	0.000854	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	1.59e-05	0.000851	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CHRM3—epilepsy syndrome	1.59e-05	0.000851	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GLUL—epilepsy syndrome	1.57e-05	0.000838	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	1.54e-05	0.000822	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.53e-05	0.000818	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.49e-05	0.000796	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.48e-05	0.000792	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.45e-05	0.000776	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	1.44e-05	0.000769	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EIF2AK2—epilepsy syndrome	1.42e-05	0.000758	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AQP1—epilepsy syndrome	1.4e-05	0.000747	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.34e-05	0.000717	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PPIA—epilepsy syndrome	1.31e-05	0.000701	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCG2—epilepsy syndrome	1.3e-05	0.000693	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.28e-05	0.000683	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	1.26e-05	0.000676	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	1.26e-05	0.000675	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CHRM3—epilepsy syndrome	1.26e-05	0.000675	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	1.26e-05	0.000672	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.25e-05	0.000667	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.18e-05	0.000629	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.15e-05	0.000616	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.14e-05	0.000608	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	1.13e-05	0.000606	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	1.08e-05	0.000577	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—BCHE—epilepsy syndrome	1.07e-05	0.000575	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCG2—epilepsy syndrome	1.03e-05	0.000551	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	1.03e-05	0.000548	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PLCB1—epilepsy syndrome	1.01e-05	0.000542	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—TH—epilepsy syndrome	1.01e-05	0.00054	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	1e-05	0.000536	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	9.97e-06	0.000533	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.95e-06	0.000532	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.9e-06	0.000529	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SLC2A1—epilepsy syndrome	9.72e-06	0.00052	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—JUNB—epilepsy syndrome	9.65e-06	0.000516	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS1—epilepsy syndrome	9.58e-06	0.000512	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	9.51e-06	0.000508	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HBEGF—epilepsy syndrome	9.14e-06	0.000489	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.03e-06	0.000483	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	9e-06	0.000481	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKT3—epilepsy syndrome	8.97e-06	0.00048	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ADAM10—epilepsy syndrome	8.76e-06	0.000468	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	8.57e-06	0.000458	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—BCHE—epilepsy syndrome	8.53e-06	0.000456	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HMOX1—epilepsy syndrome	8.43e-06	0.000451	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CAT—epilepsy syndrome	8.32e-06	0.000445	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDC42—epilepsy syndrome	8.18e-06	0.000438	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	8.14e-06	0.000435	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCB1—epilepsy syndrome	8.1e-06	0.000433	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PLCB1—epilepsy syndrome	8.05e-06	0.00043	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TH—epilepsy syndrome	8.02e-06	0.000429	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GPX1—epilepsy syndrome	7.53e-06	0.000402	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HES1—epilepsy syndrome	7.49e-06	0.000401	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FYN—epilepsy syndrome	7.29e-06	0.00039	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—H2AFX—epilepsy syndrome	7.26e-06	0.000388	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—YWHAZ—epilepsy syndrome	7e-06	0.000374	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CCR5—epilepsy syndrome	6.74e-06	0.00036	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HMOX1—epilepsy syndrome	6.7e-06	0.000358	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CAT—epilepsy syndrome	6.61e-06	0.000353	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AGT—epilepsy syndrome	6.6e-06	0.000353	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—APOE—epilepsy syndrome	6.47e-06	0.000346	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCB1—epilepsy syndrome	6.43e-06	0.000344	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TSC2—epilepsy syndrome	6.26e-06	0.000335	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APOE—epilepsy syndrome	6.13e-06	0.000328	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GPX1—epilepsy syndrome	5.98e-06	0.000319	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6ST—epilepsy syndrome	5.76e-06	0.000308	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS2—epilepsy syndrome	5.71e-06	0.000305	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—POMC—epilepsy syndrome	5.56e-06	0.000297	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AGT—epilepsy syndrome	5.24e-06	0.00028	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APOE—epilepsy syndrome	5.13e-06	0.000274	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALB—epilepsy syndrome	5.06e-06	0.000271	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGF2—epilepsy syndrome	4.66e-06	0.000249	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTGS2—epilepsy syndrome	4.43e-06	0.000237	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—POMC—epilepsy syndrome	4.41e-06	0.000236	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MTOR—epilepsy syndrome	4.24e-06	0.000227	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALB—epilepsy syndrome	4.02e-06	0.000215	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SRC—epilepsy syndrome	3.4e-06	0.000182	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AKT1—epilepsy syndrome	2.23e-06	0.000119	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKT1—epilepsy syndrome	2.11e-06	0.000113	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AKT1—epilepsy syndrome	1.77e-06	9.45e-05	CbGpPWpGaD
